Literature DB >> 18472502

Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.

A L Patel1, W A Shaikh, A K Khobragade, H G Soni, A S Joshi, G S Sahastrabuddhe.   

Abstract

We report a case of a 20 years female referred to us with a history of a brief psychotic episode for which she was given inj. Haloperidol. The patient presented in an unconscious state with high grade fever. The diagnosis was kept as neuroleptic malignant syndrome after ruling out other possibilities. The patient did not respond to Bromocriptine and Dantrolene. With the recent evidence of electroconvulsive therapy being useful in these patients, we went ahead with the same. We present this case to share our experience of the excellent response of neuroleptic malignant syndrome to electroconvulsive therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472502

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

1.  Management of common adverse effects of antipsychotic medications.

Authors:  T Scott Stroup; Neil Gray
Journal:  World Psychiatry       Date:  2018-10       Impact factor: 49.548

2.  Neuroleptic malignant syndrome: a concealed diagnosis with multitreatment approach.

Authors:  Ana Velosa; António Neves; J Bernardo Barahona-Corrêa; Albino J Oliveira-Maia
Journal:  BMJ Case Rep       Date:  2019-06-17

3.  Olanzepine-induced neuroleptic malignant syndrome in a case of multiple sclerosis.

Authors:  Deepak Hanumanthaiah; Kumar Ramanathan
Journal:  Indian J Crit Care Med       Date:  2014-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.